Accredo My Care Connect℠
With rare drug development costs ranging from $314M to $2.8B, successful launches demand the right partner. Accredo My Care Connect offers a flexible, customizable service model for exclusive, limited‑distribution, rare, and gene therapies—helping reduce treatment delays and support in‑market success.
How Accredo supports pharmaceutical partners
Communications & Digital Tools
Real‑time visibility and seamless coordination across stakeholders.
- Manufacturer and prescriber portals with HIPAA‑compliant, real‑time insights
- Patient app, text reminders, and refill‑by‑text tools
- 84% satisfaction among high‑volume advanced therapy prescribers
- 44% of prescribers choose Accredo when unrestricted
Clinical & Program Support
Specialized expertise for rare and complex therapies.
- Leading partner for exclusive and limited‑distribution therapies
- 29% exclusive and 45% limited‑distribution rare therapies
- Segmented Rare Disease TRC with expert clinical teams
- Clinicians complete 22+ hours of rare‑disease training annually
HUB Services
Flexible collaboration to reduce risk and speed access.
- Partnering with manufacturer HUBs on 75%+ of rare disease programs
- Referral and program data refreshed every 30 minutes
- Ability to serve as a HUB in select programs to reduce cost and complexity
Fulfillment & Access
Reliable delivery and continuity of care—even in challenging conditions.
- URAC‑accredited Rare Disease TRC
- 99%+ success rate for temperature‑controlled shipments
- 99.2% of reauthorizations completed before medication exhaustion
- Maintained service within 1 day during major weather events
Insights: The role of a specialty pharmacy in enhancing patient access to rare and gene therapies
Discover why Accredo is the right specialty pharmacy partner to assist manufacturers in driving the best outcomes for their rare disease and gene therapies.
